Home > Healthcare > Self-monitoring Blood Glucose Devices Market > Table of Contents

Self-monitoring Blood Glucose Devices Market - By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel & Forecast to 2032

  • Report ID: GMI2743
  • Published Date: Mar 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Self-monitoring blood glucose devices industry 3600 synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    Distribution channel trends

2.1.5    Regional trends

Chapter 3   Self-monitoring Blood Glucose Devices Industry Insights

3.1    Industry landscape, 2018 – 2032

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Rising prevalence of diabetes worldwide

3.2.1.2   Technological advancements in developed countries

3.2.1.3   Government initiatives for increasing awareness among people

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost of advanced devices and accessories in developing economies

3.2.2.2   Lack of reimbursement and stringent regulations for SMBG devices

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By application

3.3.3    By distribution channel

3.4    COVID-19 impact analysis

3.5    Regulatory landscape

3.5.1    U.S.

3.5.2    Europe

3.6    Technology landscape

3.7    Porter’s analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2021

4.1    Introduction

4.1.1    Abbott Laboratories

4.1.2    Medtronic Plc.

4.1.3    F. Hoffmann-La Roche Ltd.

4.2    Competitive dashboard, 2021

4.3    Company matrix analysis, 2021

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategic outlook matrix

Chapter 5   Self-monitoring Blood Glucose Devices Market, By Product

5.1    Key segment trends

5.2    Self-monitoring blood glucose meters

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Continuous glucose monitors

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4    Testing strips

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.5    Lancets

5.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   Self-monitoring Blood Glucose Devices Market, By Application

6.1    Key segment trends

6.2    Type 1 diabetes

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Type 2 diabetes

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Gestational diabetes

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Self-monitoring Blood Glucose Devices Market, By Distribution Channel

7.1    Key segment trends

7.2    Hospital pharmacies

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Retail pharmacies

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Online sales

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.5    Diabetes clinics & centers

7.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Self-monitoring Blood Glucose Devices Market Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Poland

8.3.7    Switzerland

8.3.8    Sweden

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Indonesia

8.4.7    Thailand

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Colombia

8.5.5    Chile

8.5.6    Peru

8.6    Middle East & Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Kuwait

8.6.4    UAE

8.6.5    Turkey

8.6.6    Egypt

8.6.7    Israel

8.6.8    Qatar

Chapter 9   Company Profiles

9.1    Abbott Laboratories

9.2    AgaMatrix

9.3    All Medicus Co., Ltd.

9.4    Ascensia Diabetes Care Holdings AG

9.5    Arkray, Inc.

9.6    B. Braun Melsungen AG

9.7    Bionime Corporation

9.8    DarioHealth Corp.

9.9    Dexcom, Inc.

9.10    Essenlife Bioscience, Inc.

9.11    F. Hoffmann-La Roche Ltd.

9.12    LifeScan Inc.

9.13    Medtronic

9.14    Nova Biomedical, Inc.

9.15    Sinocare Inc.
 

Authors: Mariam Faizullabhoy

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 285
  • Countries covered: 31
  • Pages: 182
 Download PDF